@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://fhir.ch/ig/ch-epl/RegulatedAuthorization/MA-6771901> a fhir:RegulatedAuthorization ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "MA-6771901"] ; # 
  fhir:meta [
     fhir:profile ( [
       fhir:v "http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"^^xsd:anyURI ;
       fhir:link <http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization>
     ] )
  ] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization MA-6771901</b></p><a name=\"MA-6771901\"> </a><a name=\"hcMA-6771901\"> </a><a name=\"MA-6771901-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-idmp-regulatedauthorization.html\">IDMP RegulatedAuthorization</a></p></div><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber</code>/6771901</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-Cuprior-150mg-Filmcoatedtablet.html\">MedicinalProductDefinition: extension = Film-coated tablet,CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7640109110007-6771901; domain = Human; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = gilteritinib,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product</a></p><p><b>type</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002001}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{urn:iso:std:iso:3166 CH}\">Switzerland</span></p><p><b>status</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status 756005023007}\">valid</span></p><p><b>statusDate</b>: 2021-01-21</p><p><b>holder</b>: <a href=\"#hcMA-6771901/holder-Curatis-AG\">Organization Curatis AG</a></p><p><b>regulator</b>: <a href=\"#hcMA-6771901/regulator-SMC\">Organization SMC</a></p><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Organization #holder-Curatis-AG</b></p><a name=\"MA-6771901/holder-Curatis-AG\"> </a><a name=\"hcMA-6771901/holder-Curatis-AG\"> </a><a name=\"MA-6771901/holder-Curatis-AG-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-epl-organization.html\">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href=\"NamingSystem-LOC.html\" title=\"Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)\">LOC Identifier</a>/100082791, <a href=\"NamingSystem-GLN.html\" title=\"Identifier holding a number for GLN (Global Location Number)\">GLN Identifier</a>/7640109110007</p><p><b>name</b>: Curatis AG</p></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Organization #regulator-SMC</b></p><a name=\"MA-6771901/regulator-SMC\"> </a><a name=\"hcMA-6771901/regulator-SMC\"> </a><a name=\"MA-6771901/regulator-SMC-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-epl-organization.html\">CH EPL Organization</a></p></div><p><b>identifier</b>: <a href=\"NamingSystem-LOC.html\" title=\"Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS)\">LOC Identifier</a>/100010911, <a href=\"NamingSystem-GLN.html\" title=\"Identifier holding a number for GLN (Global Location Number)\">GLN Identifier</a>/7601001398511</p><p><b>name</b>: SMC</p></blockquote></div>"^^rdf:XMLLiteral
  ] ; # 
  fhir:contained ( [
     a fhir:Organization ;
     fhir:id [ fhir:v "holder-Curatis-AG" ] ;
     fhir:meta [
       fhir:profile ( [
         fhir:v "http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"^^xsd:anyURI ;
         fhir:link <http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization>
       ] )
     ] ;
     fhir:identifier ( [
       fhir:system [ fhir:v "urn:oid:1.2.276.0.76"^^xsd:anyURI ] ;
       fhir:value [ fhir:v "100082791" ]
     ] [
       fhir:system [ fhir:v "urn:oid:2.51.1.3"^^xsd:anyURI ] ;
       fhir:value [ fhir:v "7640109110007" ]
     ] ) ;
     fhir:name [ fhir:v "Curatis AG" ]
  ] [
     a fhir:Organization ;
     fhir:id [ fhir:v "regulator-SMC" ] ;
     fhir:meta [
       fhir:profile ( [
         fhir:v "http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"^^xsd:anyURI ;
         fhir:link <http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization>
       ] )
     ] ;
     fhir:identifier ( [
       fhir:system [ fhir:v "urn:oid:1.2.276.0.76"^^xsd:anyURI ] ;
       fhir:value [ fhir:v "100010911" ]
     ] [
       fhir:system [ fhir:v "urn:oid:2.51.1.3"^^xsd:anyURI ] ;
       fhir:value [ fhir:v "7601001398511" ]
     ] ) ;
     fhir:name [ fhir:v "SMC" ]
  ] ) ; # 
  fhir:identifier ( [
     fhir:system [ fhir:v "http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber"^^xsd:anyURI ] ;
     fhir:value [ fhir:v "6771901" ]
  ] ) ; # 
  fhir:subject ( [
     fhir:link <http://fhir.ch/ig/ch-epl/MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet> ;
     fhir:reference [ fhir:v "MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet" ]
  ] ) ; # 
  fhir:type [
     fhir:coding ( [
       fhir:system [ fhir:v "http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "756000002001" ] ;
       fhir:display [ fhir:v "Marketing Authorisation" ]
     ] )
  ] ; # 
  fhir:region ( [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "CH" ] ;
       fhir:display [ fhir:v "Switzerland" ]
     ] )
  ] ) ; # 
  fhir:status [
     fhir:coding ( [
       fhir:system [ fhir:v "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "756005023007" ] ;
       fhir:display [ fhir:v "valid" ]
     ] )
  ] ; # 
  fhir:statusDate [ fhir:v "2021-01-21"^^xsd:date] ; # 
  fhir:holder [
     fhir:reference [ fhir:v "#holder-Curatis-AG" ]
  ] ; # 
  fhir:regulator [
     fhir:reference [ fhir:v "#regulator-SMC" ]
  ] . # 

# -------------------------------------------------------------------------------------

